Senti Biosciences, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-47.6% -$47M
$51M
Current Assets↓-60.5% -$36M
$23M
Cash & Equivalents↓-66.0% -$32M
$16M
ST Investments
—
Receivables
—
Net PPE↓-39.5% -$8M
$13M
Total Liabilities↓-3.1% -$1M
$46M
Current Liabilities↑+6.3% +$828K
$14M
Account Payables↑+102.4% +$1M
$3M
Stockholders Equity↓-78.2% -$20M
$6M
Retained Earnings↓-20.7% -$61M
$-359M
Operating Lease ROU Asset↓-17.4% -$2M
$12M
Operating Lease Liability↑+0.0% +$0
$29M
Gross PP&E↓-15.9% -$5M
$26M
Accumulated Depreciation↑+36.7% +$4M
$13M
Contract Liability
$43K
Contract Liability (Current)
$43K
Contract Liability (Noncurrent)
—
Remaining Performance Obligation
—